SEC Filings

S-1
AVEXIS, INC. filed this Form S-1 on 01/15/2016
Entire Document
 

 

EXHIBIT C

Development Plan

 

Revised January 2015

 

1.                                      Development Program

 

A.                                    ****

 

i.                                          ****

ii.                                       ****

iii.                                    ****

 

B.                                    ****

 

i.                                          ****

ii.                                       ****

iii.                                    ****

 

2.                                      Governmental Approval

 

A.                                    United States

B.                                    Europe — Clinical Trial Authorization

C.                                    Europe — Marketing Authorization

 

3.                                      Proposed Market Approach

 

4.                                      Competitive Information

 

A.                                    Competitive Landscape

B.                                    ****

 


**** FORTY-SEVEN PAGES HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

 

25



© AveXis, Inc. All Rights Reserved.